ZAMBON, Alfonso
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.353
EU - Europa 5.470
AS - Asia 5.200
SA - Sud America 779
AF - Africa 140
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 21.957
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.149
SG - Singapore 1.661
IT - Italia 1.431
CN - Cina 1.217
GB - Regno Unito 1.096
HK - Hong Kong 965
DE - Germania 785
SE - Svezia 643
BR - Brasile 589
VN - Vietnam 566
PL - Polonia 277
FR - Francia 240
RU - Federazione Russa 222
FI - Finlandia 198
UA - Ucraina 164
KR - Corea 161
IN - India 122
CA - Canada 102
ID - Indonesia 93
BG - Bulgaria 77
NL - Olanda 72
TR - Turchia 71
MX - Messico 69
BD - Bangladesh 62
AR - Argentina 57
IE - Irlanda 47
JP - Giappone 43
ES - Italia 41
EC - Ecuador 39
BE - Belgio 37
IQ - Iraq 34
ZA - Sudafrica 33
CO - Colombia 32
MA - Marocco 31
AT - Austria 29
MY - Malesia 28
AE - Emirati Arabi Uniti 23
VE - Venezuela 22
PK - Pakistan 21
IR - Iran 18
DZ - Algeria 15
EG - Egitto 15
TH - Thailandia 15
CH - Svizzera 14
LT - Lituania 14
RO - Romania 13
UZ - Uzbekistan 13
CL - Cile 12
KE - Kenya 12
PH - Filippine 12
TN - Tunisia 12
CZ - Repubblica Ceca 11
PY - Paraguay 11
SA - Arabia Saudita 10
AU - Australia 8
IL - Israele 8
PE - Perù 8
PT - Portogallo 8
BY - Bielorussia 7
DO - Repubblica Dominicana 7
GE - Georgia 7
JO - Giordania 7
HU - Ungheria 6
RS - Serbia 6
AZ - Azerbaigian 5
DK - Danimarca 5
ET - Etiopia 5
KZ - Kazakistan 5
LK - Sri Lanka 5
NP - Nepal 5
TT - Trinidad e Tobago 5
AL - Albania 4
BO - Bolivia 4
LB - Libano 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
AO - Angola 3
CR - Costa Rica 3
JM - Giamaica 3
KG - Kirghizistan 3
LU - Lussemburgo 3
OM - Oman 3
PA - Panama 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
BH - Bahrain 2
BS - Bahamas 2
BZ - Belize 2
EE - Estonia 2
EU - Europa 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
LV - Lettonia 2
MK - Macedonia 2
ML - Mali 2
NG - Nigeria 2
NI - Nicaragua 2
SI - Slovenia 2
UG - Uganda 2
Totale 21.930
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.101
Singapore 1.092
Fairfield 1.030
Hong Kong 940
Ashburn 859
Woodbridge 629
Southend 576
Chandler 568
Houston 495
Modena 481
Ann Arbor 439
Nyköping 384
Seattle 381
Cambridge 375
Hefei 372
Frankfurt am Main 350
Wilmington 327
San Jose 317
London 293
Warsaw 256
Beijing 243
Jacksonville 227
Dearborn 222
Ho Chi Minh City 190
Helsinki 176
Los Angeles 164
Council Bluffs 148
Dallas 147
Hanoi 145
The Dalles 144
Chicago 140
Seoul 140
Berlin 106
Bologna 95
San Diego 84
New York 77
Princeton 75
Reggio Emilia 74
Sofia 74
Bremen 73
Eugene 65
Lauterbourg 65
Jakarta 63
Moscow 60
Salt Lake City 58
Boardman 54
Orem 52
São Paulo 49
Munich 45
Dublin 42
Buffalo 39
Shanghai 39
Parma 34
Redondo Beach 34
Formigine 33
Brussels 32
Amsterdam 31
Izmir 31
Tokyo 31
Da Nang 30
Redwood City 30
Atlanta 26
Tampa 26
Milan 25
Montreal 25
Chennai 24
Stockholm 24
Denver 22
Toronto 22
Wimbledon 22
Bomporto 21
Kent 21
Rio de Janeiro 21
Vancouver 21
Elk Grove Village 20
Falls Church 19
Norwalk 19
Brooklyn 18
Rome 18
Newark 17
Nuremberg 17
Voghera 17
Belo Horizonte 16
Johannesburg 16
Lappeenranta 16
Mexico City 16
Haiphong 15
Madrid 15
Paris 15
Des Moines 14
Florence 14
Guangzhou 14
Manchester 14
Phoenix 14
Guayaquil 13
Poplar 13
Tashkent 13
Turin 13
Columbus 12
Dhaka 12
Totale 15.626
Salva come PNG Salva come JPEG
Nome #
1 - ( 5 - TERT - BUTYL - 2 - ARYL - PYRAZOL - 3 - YL ) . 3 - 12 - FLUORO - 4 - [ ( 3 - OXO - 4H - PYRIDO [ 2 . 3 - BJPYRAZIN - 8 - YL ) OXY | PHENYLJUREA DERIVATIVES AS RAF INHIBITORS FOR THE TREATMENT OF CANCER 966
Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure-Activity Relationships 572
Chiral polycyclic ketones via desymmetrization of dihaloolefins 428
Potential of wickerhamomyces anomalus in glycerol valorization 409
Cytocompatibility of potential bioactive cerium-doped glasses based on 45S5 368
BRAF inhibitors induce metastasis in RAS mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signaling 352
Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma 348
Nucleoside 2’,3’-cyclic monophosphates in Aphanizomenon flos-aquae detected through nuclear magnetic resonance and mass spectrometry 343
A novel mechanism for the fluxional behaviour of [Pd(η2-tetramethylethylenetetracarboxylate)(2-methylthiomethylpyridine)] 331
A novel protocol for the one-pot borylation/Suzuki reaction provides easy access to hinge-binding groups for kinase inhibitors 325
Cerium Containing Bioactive Glasses: A Review 320
Abstract 3704: Novel panRAF inhibitors active in melanomas that are resistant to BRAF-selective, or BRAF-selective/MEK inhibitor combinations 318
A novel, selective, and efficacious nanomolar pyridopyrazinone inhibitor of V600EBRAF 314
BRAF inhibitors based on an imidazo[4,5]pyridin-2-one scaffold and a meta substituted middle ring 312
Assessment of chloroaniline toxicity by the submitochondrial particle assay 305
Development of novel, highly potent inhibitors of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF): Increasing cellular potency through optimization of a distal heteroaromatic group 302
Characterization of compound 584, an Abl kinase inhibitor with lasting effects 302
BRAF as a therapeutic target: A patent review (2006-2012) 301
Mesoporous bioactive glasses doped with cerium: Investigation over enzymatic-like mimetic activities and bioactivity 297
Boosting sunscreen stability: New hybrid materials from UV filters encapsulation 297
Novel hinge binder improves activity and pharmacokinetic properties of BRAF inhibitors 292
Structure Model and Toxicity of the Product of Biodissolution of Chrysotile Asbestos in the Lungs 291
Investigation on the antimicrobial properties of cerium-doped bioactive glasses 280
1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy 273
Thiophene based A-D-A small molecules with a dithienosilole core: synthesis, theoretical calculations and optoelectronic properties 266
β-Glucuronidase Pattern Predicted From Gut Metagenomes Indicates Potentially Diversified Pharmacomicrobiomics 261
Ce-MBGs Loaded with Gentamicin: Characterization and In Vitro Evaluation 256
Development and exploitation of CK2 inhibitors 254
Tris-annelated benzenes selectively perfunctionalized on one side only: Hexachlorobenzotrinorbornadiene as a versatile scaffold for the construction of molecular domes 253
Novel Potent BRAF Inhibitors: Toward 1 nM Compounds through Optimization of the Central Phenyl Ring 249
The discovery of novel, highly potent inhibitors of BRAF 243
Non canonical Cyclic Nucleotides Monophosphates in Aphanizomenon flosaquae: nuclear magnetic resonance and mass spectrometry 241
Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors 240
Potent BRAF kinase inhibitors based on 2,4,5-trisubstituted imidazole with naphthyl and benzothiophene 4-substituents 239
Substituted aniline interaction with submitochondrial particles and quantitative structure-activity relationships 236
Study on the toxicity of phenolic and phenoxy herbicides using the submitochondrial particle assay 234
"Hexacarboxytrindanes": Benzene rings with homotopic faces as scaffolds for the construction of D3 chiral architectures 233
Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds 233
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors 233
Efficient access to 5-substituted thiazoles by a novel metallotropic rearrangement 231
1-(5-TERT-BUTYL-2-ARYL-PYRAZOL-3-YL)-3-2-FLUORO-4-(3-OXO-4H-PYRIDO2,3-BPYRAZIN-8-YL)OXYPHENYLUREA DERIVATIVES AS RAF INHIBITORS FOR THE TREATMENT OF CANCER 229
Internal motions in a fulleropyrrolidine tertiary amide with axial chirality 228
Pyridoimidazolones as novel potent inhibitors of v-Raf murine sarcoma viral oncogene homologue B1 (BRAF) 228
Topical 5-Fluorouracil Elicits Regressions of BRAF Inhibitor–Induced Cutaneous Squamous Cell Carcinoma 228
Surface acidity modifications induced by thermal treatments and acid leaching on microcrystalline H-BEA zeolite. A FTIR, XRD and MAS-NMR study 226
Isolation and characterization of all eight bisadducts of fulleropyrrolidine derivatives 225
Synthesis of the syn and anti isomer of 1,4,5,8,9,12-hexahydro-2,3,6,7,10,11-hexamethylidene-1,4 : 5,8 : 9,12-trimethanotriphenylene and Diels-Alder reactivity of the syn isomer 225
Gatekeeper mutations mediate resistance to BRAF-targeted therapies 222
Novel oligothiophenes with reduced HOMO-LUMO band gap for Optoelectonics 222
Synthesis and evaluation of antiparasitic activities of new 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine derivatives 219
Synthesis and evaluation of new chiral diols based on the dicyclopentadiene skeleton 216
Small molecule inhibitors of BRAF in clinical trials 216
ANTIPROLIFERATIVE COMPOUNDS AND THERAPEUTIC USES THEREOF 214
Loading with Biomolecules Modulates the Antioxidant Activity of Cerium-Doped Bioactive Glasses 214
Nucleophilic reactions at the ring carbons of thiiranium and thiirenium ions. An experimental and theoretical comparison of the S(N)2 and S(N)2-Vin mechanisms 210
Bifunctional mesoporous glasses for bone tissue engineering: Biological effects of doping with cerium and polyphenols in 2D and 3D in vitro models 207
Efficient cyclotrimerization of bicyclic vic-bromostannylalkenes promoted by copper(I) thiophen-2-carboxylate 207
Dual Kinase Targeting in Leukemia 202
Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma 197
ANTIPROLIFERATIVE COMPOUNDS AND THERAPEUTIC USES THEREOF 197
Expedient Access to Type II Kinase Inhibitor Chemotypes by Microwave-Assisted Suzuki Coupling 197
Qualitative and quantitative discrimination of fake and true alkene rotation processes in pd(η2-olefin) complexes. A new bimolecular mechanism 196
Non-canonical Cyclic Nucleoside Monophosphates in Aphanizomenon flos-aquae: nuclear magnetic resonance and mass spectrometry 189
Evaluation of the Properties of Bioactive Mesoporous Glasses Doped with Cerium and Loaded with Polyphenols 185
Biostimulants derived from organic urban wastes and biomasses: An innovative approach 176
Synthetic approach to novel NMP/ALK inhibitors 171
Cytocompatibility of mesoporous bioactive glasses doped with cerium and loaded with polyphenols 168
Toward the Scale-Up of a Bicyclic Homopiperazine via Schmidt Rearrangement and Photochemical Oxaziridine Rearrangement in Continuous-Flow 165
α‐Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML 162
Paradoxical activation of the MEK/ERK pathway promotes melanoma invasion and metastasis 160
NON CANONICAL CYCLIC NUCLEOTIDES MONOPHOSPHATES IN APHANIZOMENON FLOS-AQUAE: NUCLEAR MAGNETIC RESONANCE AND MASS SPECTROMETRY 159
Rational design of inhibitors of the anaplastic lymphoma kinase 158
endo-1-Phenylborneol as a novel, alternative chiral auxiliary for the aza-Diels-Alder reaction 158
Evaluation of the behaviour of hydrogels containing mesoporous glasses doped with cerium and loaded with polyphenols 154
LYSYL OXIDASE INHIBITORS 154
Extraction, purification and in vitro assessment of the antioxidant and anti-inflammatory activity of policosanols from non-psychoactive Cannabis sativa L. 153
Erratum: Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase (ACS Omega (2022) 7:20 (17083-17097) DOI: 10.1021/acsomega.2c00507) 151
Identification of non-ATP-competitive α-carboline inhibitors of the anaplastic lymphoma kinase 150
Dual loaded Ce-MBGs with bioactivity, antioxidant and antibacterial properties 148
Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase 143
Preparation of 1-​(5-​tert-​butyl-​2-​aryl-​pyrazol-​3-​yl)​-​3-​[2-​fluoro-​4-​[(3-​oxo-​4H-​pyrido[2,​3-​b]​pyrazin-​8-​yl)​oxy]​phenyl]​urea derivatives as RAF inhibitors for treating cancer 135
The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers 132
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 127
Double-ion doped mesoporous glasses: Studies on stability, antibacterial and antioxidant properties, and bioactivity 125
Erratum: Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma (Cancer Cell (2015) 27(1) (85–96) (S1535610814004577) (10.1016/j.ccell.2014.11.006)) 120
Novel ligands from direct benzylic functionalisation of tris(2-pyridylmethyl)amine 117
Long-term durability of discarded cork-based composites obtained by geopolymerization 113
Corrections to pyridoimidazolones as novel potent inhibitors of v-raf murine sarcoma viral oncogene homologue B1 (BRAF) (Journal of Medicinal Chemistry (2009) 52, (2255-2256) DOI: 10.1021/jm801509w) 106
PROCESS FOR THE PREPARATION OF 8-(4-AMINOPHENOXY)-4H PYRIDO2,3-B PYRAZIN-3-ONE DERIVATIVES 105
Polyphosphate coacervate gels for manufacturing of manganese loaded glass powders and fibres: structural, cytocompatibility and surface bioactivity study 100
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 98
Erratum: Topical 5-fluorouracil elicits regressions of BRAF inhibitor-induced cutaneous squamous cell carcinoma (Journal of Investigative Dermatology (2013) 133 (274-276) DOI: 10.1038/jid.2012.268;0 95
Enhanced bone regeneration with cerium-doped bioactive glasses: In vitro and in vivo study 91
Materiale fotoassorbente ad ampio spettro, procedimento per la sua preparazione ed usi relativi 71
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 71
Gelatin/Cerium-Doped Bioactive Glass Composites for Enhancing Cellular Functions of Human Mesenchymal Stem Cells (hBMSCs) 67
Targeting monocarboxylate transporter 1 with a copper-chelating coumarin-based bioconjugate: Synthesis and characterization 65
Negative Allosteric Modulators of A2AR: A New Weapon for Cancer Immunotherapy? 65
Discovery of selective, metabolically stable pyrazole-based FLT3 inhibitors for the treatment of acute myeloid leukemia 59
UV filters Encapsulation in Zeolites 47
Totale 22.086
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.236
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.236
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021448 0 0 0 0 0 0 0 0 0 194 135 119
2021/20221.666 95 210 201 58 73 89 99 82 188 96 288 187
2022/20231.967 245 218 134 187 258 249 71 176 246 46 76 61
2023/20241.625 52 94 110 97 514 43 278 178 43 48 52 116
2024/20254.053 126 43 125 203 806 566 214 319 564 224 398 465
2025/20267.183 425 326 694 901 1.077 999 887 422 736 716 0 0
Totale 22.120